GlassScriptPhysician profile
Kellie Whitener
NPI 1093301855
$5,041.18
in general payments reported to CMS, 2019-2025
46 companies · $989 in 2025
The $989 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $811 · 2022: $728 · 2023: $1,421 · 2024: $1,091 · 2025: $989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,501.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $832.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $504.06 | 2021-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Novo Nordisk INC | $443.19 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $368.54 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Amgen INC. | $365.35 | 2021-2024 | Repatha, Prolia, Evenity |
| Lilly USA, LLC | $323.42 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $220.36 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $198.39 | 2021-2024 | Spravato |
| Pfizer INC. | $143.64 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.51 | 2024-2025 | Xifaxan, Trulance |
| Tris Pharma INC | $115.94 | 2023-2024 | Dyanavel Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $97.45 | 2025 | Caplyta |
| Corium, LLC | $92.37 | 2021-2024 | Azstarys |
| Sanofi Pasteur INC. | $84.51 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $80.71 | 2021-2023 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Whitener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.